84 results on '"Pérez García R"'
Search Results
2. Sistema Ultracontrol® en la clínica diaria de la hemodiafiltración en línea posdilucional: volumen de infusión alcanzado y aplicabilidad con distintos dializadores
- Author
-
Albalate Ramón, M., Pérez García, R., Sequera Ortiz, P. de, Alcázar Arroyo, R., Corchete Prats, E., Puerta Carretero, M., Ortega Díaz, M., and Mosse, A.
- Subjects
hemodiafiltration ,Dializador ,Alarmas ,Infusión ,Dialyzer ,Infusion ,Alarm ,Ultracontrol® ,Hemodiafiltración - Abstract
Introducción: Estudios recientes indican que los beneficios en la supervivencia con hemodiafiltración en línea posdilucional (HDFOL-post) se logran si el volumen de infusión (Vinf) es superior a 20 l por sesión, cifra que no es fácil lograr por los problemas que genera la hemoconcentración. Hoy día contamos con técnicas automáticas que logran un mayor rendimiento minimizando el número de alarmas como el Ultracontrol® (UltraC). Objetivo: El objetivo ha sido, en una primera parte, evaluar el UltraC para conocer qué rendimiento logra (expresado como la fracción de filtración [FF] y el Vinf) y los problemas que presenta y, en una segunda parte, estudiar su funcionamiento con cuatro dializadores diferentes. Material y métodos: Primera parte. Nueve pacientes fueron transferidos a HDFOL-post con UltraC. Se recogieron todas las sesiones correspondientes a los tres primeros meses con HDF-OL y al mes previo en HD. Segunda parte. 18 pacientes en tratamiento crónico con HDFOL-post fueron sometidos a diálisis una semana con cada uno de estos dializadores: FX1000, FX800, Polyflux210 y Elisio 210H. Resultados: Primera parte. En 3 pacientes surgieron problemas asociados a PTM y Psist inadecuadas que se resolvieron pasando a control-presión. Los valores medios obtenidos fueron: Qb máximo 441 (21) (rango 350-490) ml/min, Vinf 26,3 (3,3) l/sesión, FF 30,6% (2,5), KT 59,9 (5) l/sesión, y aumento del KT del 12% respecto al de HD. Segunda parte. Polyflux210 fue el dializador que precisó menos retiradas de UltraC. Las presiones recogidas tanto PTM como Psist fueron distintas y determinaron la necesidad de retirada del sistema. El KT fue adecuado. Conclusiones: a) El sistema UltraC alcanza FF del 30% consiguiendo Vinf adecuados con mínimas alarmas, y b) Dializadores con prestaciones depurativas adecuadas pueden no ser útiles para realizar HDF-OL con UltraC porque sus condiciones flujodinámicas generan alarmas que impiden la aplicación automatizada aunque el rendimento final sea semejante. Introduction: Recent studies indicate that the survival benefit with post-dilution on line hemodiafiltration (OL-HDF-post) are achieved if the infusion volume (Vinf) is greater than 20L per session, a goal that is not easily achieved due to hemoconcentration problems. Today we have automated techniques to achieve higher performance minimizing the number of alarms as Ultracontrol® (Ultrac). The objective in the first part of study was to evaluate the UltraC performance (expressed as the filtration fraction (FF) and Vinf) and which problems it presents, and in the second part, to study its performance with four different dialyzers. Material and methods: 1st period. Nine patients were transferred to OL-HDF-post with UltraC. The first 3 months on OL-HDF all sessions were recorded and compared with hemodialysis sessions in the previous month. 2nd part: 18 patients on chronic OL-HDF-post were dialyzed for a week with each of these dialyser: FX1000, FX800, Elisio210H and Polyflux210. Results: 1st period: In 3 patients, problems associated with inappropriate pressures emerged. In 3 patients there were problems associated with inadequate PTM and Psist that resolved changing to pressure control. Mean values were: maximum Qb 441 (21) (range 350-490) ml/min, Vinf 26.3 (3.3) l/session, FF 30.6 (2.5)%, KT 59.9 (5) l/session. KT increase of 12% compared to HD. 2nd part: Polyflux210 required less UltraC withdrawals than the others. Different PTM or Psist were found and determined the need for removal of the system. The KT was adequate. Conclusions: a) The UltraC system reaches FF of 30% with minimal alarms and Vinf higher than 20 l. b) Structural characteristics of dialysers can limit their use with UltraC although they managed to desirable KT and Vinf in a manual way.
- Published
- 2011
3. ¿Hemos olvidado lo más importante para prevenir las bacteriemias en pacientes portadores de catéteres para hemodiálisis?
- Author
-
Albalate, M., Pérez García, R., Sequera, P. de, Alcázar, R., Puerta, M., Ortega, M., Mossé, A., and Crespo, E.
- Subjects
Hemodiálisis ,Prevención ,Hemodialysis ,Prevention ,Catéter tunelizado ,Bacteriemia ,Bacteremia ,Tunneled catheter - Abstract
La bacteriemia relacionada con el catéter (BRC) en pacientes en hemodiálisis (HD) es una complicación grave. Existen múltiples publicaciones que abogan por el uso de diferentes medidas farmacológicas para su prevención, pero muy pocas sobre la importancia de las medidas de precaución universal. El objetivo de este trabajo es mostrar la baja tasa de incidencia de BRC obtenida con la aplicación estricta de un protocolo de cuidados de catéter tunelizado (CT) por un personal bien entrenado en una nueva unidad de hemodiálisis. Durante 20 meses se aplicó un protocolo de manejo de CT por personal de enfermería cualificado. Se utilizaron un total de 42 CT en 32 pacientes. El tiempo total de seguimiento fue de 8.372 días en los que ocurrieron dos episodios de BRC: 0,24 eventos/1.000 días-catéter. El trabajo muestra cómo sólo con medidas de precaución universal pueden lograrse tasas de BRC dentro de la excelencia. Bacteremia associated with tunneled central venous catheters (CVC) is a major complication in hemodialysis patients. Strategies that aim to prevent catheter-related bacteremia (CRB), ranging from the application of topical antibiotics to the use of different catheter-lock solutions, have been studied, but limited interest has been shown about following standardization of aseptic care and maintenance of CVC by experienced staff. This study reports CRB incidence obtained with a strict infection prophylaxis protocol based on universal precautions against infection adopted in our Unit by qualified nursing hemodialysis staff. During a period of 20 months, 32 patients received 42 CVC. There were 2 CRB, with an incidence of 0,24 CRB/1000 days-catheter. This study shows that an optimal catheter-use management reduces the incidence of CRB to excellent rates. The use of a protocol directed to vigorously protect the catheter at the time of usage by specialized teams is critically important and is highly recommended.
- Published
- 2010
4. Dispositivo de medición del rango de movimiento articular de la columna vertebral en los planos sagital y frontal. 'Spinal Mouse'
- Author
-
Pérez García, R., Navarro Navarro, Ricardo, Ruiz Caballero, José Antonio, Jiménez Díaz, J.F., and Brito Ojeda, M. Estrella
- Subjects
32 Ciencias médicas ,3213 Cirugía - Published
- 2006
5. Análisis cinesiológico de la acción muscular del periné y de la región sacra
- Author
-
Pérez García, R., Navarro Navarro, Ricardo, Ruiz Caballero, José Antonio, Jiménez Díaz, J.F., and Brito Ojeda, M. Estrella
- Subjects
32 Ciencias médicas ,3213 Cirugía - Published
- 2006
6. Programa multifactorial para la prevención de caídas: un proyecto multifactorial en el ámbito rural
- Author
-
Pérez García, R., González González, J., Corregidor Sánchez, A.I., and Criado Álvarez, J.J.
- Published
- 2016
- Full Text
- View/download PDF
7. Preocupante incremento de la diabetes como causa de insuficiencia renal terminal: Evaluación del tratamiento sustitutivo
- Author
-
Pérez García, R., Rodríguez Benítez, P., Dall´Anesse, C., Gómez Campderá, F., and Valderrábano, F.
- Subjects
Transplantation ,Trasplante renal ,Renal replacement therapy ,Epidemiology ,Diabetes ,Mortalidad ,Peritoneal dialysis ,Diálisis ,Epidemiología ,Mortality ,Tratamiento sustitutivo de la función renal - Abstract
Objetivo: Valorar la incidencia, prevalencia, tipo de tratamiento y pronóstico de pacientes diabéticos en tratamiento sustitutivo de la función renal (TSFR). Material: Se estudia a todos los pacientes diabéticos con insuficiencia renal terminal en TSFR en el Área Sanitaria 1 de Madrid desde 1978 hasta 1998. Resultados: La diabetes mellitus se ha convertido en la principal causa de insuficiencia renal terminal en nuestra área sanitaria, constituyendo en la actualidad el 30% de todas las causas de entrada en TSFR. La incidencia de diabéticos que comenzaron en 1998 TSFR fue de 33,3 pmp, claramente superior a la del periodo 1993-94, 21 pmp. La prevalencia de pacientes diabéticos en TSFR en 1998 fue de 135 pmp, con una prevalencia global de 1054 pmp. Se ha incrementado la proporción de diabéticos tipo 2 con respecto al global de pacientes diabéticos que inician tratamiento sustitutivo, pasando de ser un 15% en 1987-88 a un 81% en 1997-98. De manera simultánea, se ha incrementado la edad media de dichos pacientes, pasando de ser 47 años antes de 1988 a 63 años en 1997-98. En total se estudian 182 diabéticos, 106 hombres y 76 mujeres. 105 eran diabéticos tipo 1 y 77 tipo 2, con una edad media al comienzo del TSFR de 57 12 años. La hemodiálisis (HD) fue la primera modalidad de tratamiento en 128 pacientes y la diálisis peritoneal (DP) en 54. Los pacientes que iniciaban DP eran 5 años más jóvenes que los que iniciaban HD, p
- Published
- 2001
8. Actitud básica de emergencia ante una parada cardiorrespiratoria pediátrica
- Author
-
Rumbo-Prieto JM, Pérez-García R, Loureiro-Pérez N, Darriba-Rodríguez P, and Mosquera-Estévez P
- Published
- 1999
- Full Text
- View/download PDF
9. [Comorbidity of dual pathology and behavioral disorders in adolescence].
- Author
-
Pérez García R and Pérez García M
- Subjects
- Humans, Adolescent, Comorbidity, Mental Disorders epidemiology
- Published
- 2024
- Full Text
- View/download PDF
10. La eficacia simbólica en la prescripción de psicofármacos.
- Author
-
Pérez-García R and Pérez-García M
- Published
- 2024
11. [Bereavement for widowhood: A silent problem in primary care].
- Author
-
Pérez García R and Pérez García M
- Subjects
- Humans, Female, Male, Aged, Primary Health Care, Widowhood psychology, Bereavement
- Published
- 2023
- Full Text
- View/download PDF
12. [The symbolic foundation of gender violence in the healthcare workplace.]
- Author
-
Pérez García R, Pérez García M, and Pérez García D
- Subjects
- Humans, Spain, Violence, Workplace, Delivery of Health Care, Health Personnel, Gender-Based Violence prevention & control, Workplace Violence prevention & control
- Published
- 2023
13. [Burnout syndrome and adverse effects: The unavoidable prevention].
- Author
-
López-Cortacans G, Pérez-García M, Pérez-García R, and Pérez-García D
- Subjects
- Humans, Burnout, Professional prevention & control, Burnout, Psychological
- Published
- 2021
- Full Text
- View/download PDF
14. Factors associated with falls in hemodialysis patients: a case-control study.
- Author
-
Perez-Gurbindo I, María Álvarez-Méndez A, Pérez-García R, Cobo PA, and Carrere MTA
- Subjects
- Blood Pressure, Case-Control Studies, Humans, Renal Dialysis, Retrospective Studies, Risk Factors, Hemodialysis Units, Hospital, Hypertension
- Abstract
Objective: to identify possible associations between a higher probability of falls among hemodialysis patients and laboratory values, comorbidities, pharmacological treatment, hemodynamic changes, dialysis results and stabilometric alterations., Method: this was a retrospective case-control study with hemodialysis patients. Patients in a hemodialysis unit who had suffered one or more falls were included in the case group. Patients from the same unit who had not suffered falls were the controls. Data were gathered from the patients' clinical history and also from the results of a balance test conducted six months before the study., Results: thirty-one patients were included (10 cases and 21 controls). Intradialytic body weight change was significantly greater among cases (p <0.05). Patients in the case group also presented greater lateral instability after dialysis (p <0.05). Other factors such as high blood pressure, antihypertensives, beta-blockers, and lower heart rates were also associated with falls., Conclusion: a greater intradialytic weight change was associated with an increase in risk of falls. Nursing staff can control these factors to prevent the incidence of falls in dialysis patients.
- Published
- 2021
- Full Text
- View/download PDF
15. Advantages of the use of citrate over acetate as a stabilizer in hemodialysis fluid: A randomized ABC-treat study.
- Author
-
de Sequera P, Pérez-García R, Molina M, Álvarez-Fernández G, Muñoz-González RI, Mérida E, Camba MJ, Blázquez LA, Alcaide MP, and Echarri R
- Abstract
Hemodialysis (HD) with bicarbonate dialysis fluid (DF) requires the presence of an acid to prevent the precipitation of calcium and magnesium carbonate. The most used acid is acetic acid, with it several complications have been described. In a previous work, we described the acute changes during an HD session with a DF with citrate instead of acetate. Now, we report the results in the medium term, 16 weeks. It is a prospective, multicenter, crossover and randomized study, where 56 HD patients with bicarbonate three times a week were dialysed for 16 weeks with 3mmol/L acetate and 16 weeks with 1mmol/L citrate. Patients older than 18 years with a previous stay on HD of more than 3 months and with a normal functioning arteriovenous fistula were included. Epidemiological data, dialysis, bioimpedance, biochemistry before and after HD, as well as hypotensive episodes, were collected monthly. After 16 weeks of citrate treatment, pre-HD ionic calcium and magnesium were significantly lower and paratiroid hormone (PTH) higher than in the acetate period. No differences were observed in the effectiveness of dialysis. Hypotensive episodes were significantly more frequent with acetate than with citrate: 311 (14.1%) vs 238 (10.8%) sessions. The lean mass index increased by 0.96±2.33kg/m
2 when patients switched from DF with acetate to citrate. HD with citrate modifies several parameters of bone mineral metabolism, not only acutely as previously described, but also in the long-term. The substitution of acetate for citrate improves hemodynamic stability, producing less hypotension and can improve nutritional status., (Copyright © 2021 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
16. Haemodialysis patients have worse postural balance with an associated risk of falls.
- Author
-
Pérez-Gurbindo I, Angulo Carrere MT, Arribas Cobo P, Puerta M, Ortega M, Jaldo MT, de Sequera P, Alcázar R, Pérez-García R, and Álvarez-Méndez AM
- Subjects
- Accidental Falls prevention & control, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Humans, Incidence, Male, Middle Aged, Prospective Studies, Sensation Disorders diagnosis, Sensation Disorders physiopathology, Accidental Falls statistics & numerical data, Postural Balance drug effects, Postural Balance physiology, Renal Dialysis, Sensation Disorders complications
- Abstract
Introduction: Postural balance is the result of a complex interaction of sensory input which keeps us upright. Haemodialysis patients have alterations which can lead to postural instability and a risk of falls. Our objective was to analyse postural stability and its relationship with the risk of falls in haemodialysis patients using a force platform., Material and Methods: This was a prospective cross-sectional study. Postural balance was recorded using a force platform in prevalent haemodialysis patients. We collected epidemiological, dialysis, analytical and treatment data. The incidence of falls was recorded over the 6 months following the tests. The postural stability analysis was performed with a portable strain gauge platform (AMTI AccuGait®) and a specific software unit for stabilometry (Balance Trainer® program). We measured 31 balance parameters; the balance variables used were: Area95; AreaEffect; VyMax; Xrange and Yrange. The stabilometry studies were performed in 3 situations: with eyes open; with eyes closed; and with the patient performing a simultaneous task. We performed one study at the start of the dialysis session, and a second study at the end. Stabilometry was measured in a control group under similar conditions., Results: We studied 32 patients with a mean age of 68 years old; of this group, 20 subjects were male and 12 were female. Their mean weight was 74kg, with a mean BMI of 27.6kg/m
2 . In the controls, there were no significant differences in the stabilometry between the 3 situations studied. Both pre- and post-haemodialysis, patients with closed eyes showed greater imbalance, and there were significant differences with the other situations and controls. We found a significant increase in instability after the haemodialysis session, and greater instability in the 13 patients with diabetes (P<.05). The 4 patients with hyponatraemia (Na<136mmol/l) had worse balance in the simultaneous task situation (P=.038). Various drugs, such as insulin (P=.022), antiplatelet agents (P=.036) and beta-blockers (P=.029), were associated with imbalance. The 10 patients who suffered falls had greater imbalance, Yrange, Xrange, Area95 and AreaEffect, both pre- and post-haemodialysis (P<.05) than those without falls., Conclusions: Haemodialysis patients have alterations which can lead to postural instability and a risk of falls. Prevention programmes which include specific exercises to improve balance could be beneficial in reducing the risk of falls in this population., (Copyright © 2020 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
17. Hypomagnesaemia in haemodialysis is associated with increased mortality risk: its relationship with dialysis fluid.
- Author
-
Pérez-García R, Jaldo MT, Puerta M, Ortega M, Corchete E, de Sequera P, Martín-Navarro JA, Albalate M, and Alcázar R
- Subjects
- Adult, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Kidney Failure, Chronic therapy, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Dialysis Solutions, Kidney Failure, Chronic blood, Kidney Failure, Chronic mortality, Magnesium blood, Renal Dialysis
- Abstract
Hypomagnesaemia in haemodialysis (HD) is associated with increased mortality risk: its relationship with dialysis fluid (DF)., Introduction: Low concentrations of magnesium (Mg) in blood have been linked to the development of diabetes, hypertension, arrhythmias, vascular calcifications and an increased risk of death in the general population and in haemodialysis patients. The composition of the dialysis fluid in terms of its magnesium concentration is one of the main determinants of magnesium in haemodialysis patients., Objective: To study magnesium concentrations in haemodialysis patients, their predictive mortality rate and what factors are associated with hypomagnesaemia and mortality in haemodialysis., Methods: Retrospective study of a cohort of prevalent haemodialysis patients followed up for two years. Serum magnesium was measured every six months. The analysis used the initial and average magnesium values for each patient, comparing patients with magnesium below the mean (2.1mg/dl) with those with magnesium above the mean. During the follow-up, three types of dialysis fluid were used: type 1, magnesium 0.5 mmol/l; type 3, magnesium 0.37 mmol/l (both with acetate); and type 2, magnesium 0.5 mmol/l with citrate., Results: We included 137 haemodialysis patients in the study, of which 72 were male and 65 were female, with a mean age of 67 (15) [26-95] years old. Of this group, 57 patients were diabetic, 70 were on online haemodiafiltration (OL-HDF) and 67 were on high-flow haemodialysis (HF-HD). The mean magnesium of the 93 patients with dialysis fluid type 1 was 2.18 (0.37) mg/dl. In the 27 patients with dialysis fluid type 3 it was 2.02 (0.42) mg/dl. And in the 17 with dialysis fluid type 2 it was 1.84 (0.24) mg/dl (p=.01). There was a pronounced direct relationship between Mg and P and albumin. After a mean follow-up of 16.6 (8.9) [3-24] months, 77 remained active, 24 had died and 36 had been transplanted or transferred. Patients with magnesium above than 2.1mg/dl had a longer survival (p=.008). The survival of patients with the three types of dialysis fluid did not differ significantly (Log-Rank, p=.424). Corrected for blood magnesium, patients with dialysis fluid with citrate have better survival (p=.009). The COX regression analysis shows how age, serum albumin, magnesium, dialysis technique and type of dialysis fluid have an independent predictive mortality rate., Conclusions: Low serum magnesium levels have a greater association with an increased risk of mortality compared to high levels. The type of dialysis fluid affects the magnesium concentration and the risk of death., (Copyright © 2020 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
18. Prospective randomised multicentre study to demonstrate the benefits of haemodialysis without acetate (with citrate): ABC-treat Study. Acute effect of citrate.
- Author
-
de Sequera Ortiz P, Pérez García R, Molina Nuñez M, Muñoz González RI, Álvarez Fernández G, Mérida Herrero E, Camba Caride MJ, Blázquez Collado LA, Alcaide Lara MP, and Echarri Carrillo R
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Over Studies, Female, Humans, Male, Middle Aged, Prospective Studies, Treatment Outcome, Young Adult, Acetates administration & dosage, Citrates administration & dosage, Hemodialysis Solutions chemistry, Renal Dialysis methods
- Abstract
Introduction: Dialysis fluid (DF), an essential element in hemodialysis (HD), is manufactured in situ by mixing three components: treated water, bicarbonate concentrate and acid concentrate. To avoid the precipitation of calcium and magnesium carbonate that is produced in DF by the addition of bicarbonate, it is necessary to add an acid. There are 2 acid concentrates that contain acetate (ADF) or citrate (CDF) as a stabilizer., Objective: To compare the acute effect of HD with CDF vs. ADF on the metabolism of calcium, phosphorus and magnesium, acid base balance, coagulation, inflammation and hemodynamic stability., Methods: Prospective, multicenter, randomized and crossed study, of 32 weeks duration, in patients in three-week HD, AK-200-Ultra-S or Artis monitor, 16 weeks with ADF SoftPac
® , prepared with 3mmol/L of acetate, and 16 weeks with CDF SelectBag Citrate® , with 1mmol/L of citrate. Patients older than 18 years were included in HD for a minimum of 3 months by arteriovenous fistula. Epidemiological, dialysis, pre and postdialysis biochemistry, episodes of arterial hypotension, and coagulation scores were collected monthly during the 8 months of the study. Pre and post-dialysis analysis were extracted: venous blood gas, calcium (Ca), ionic calcium (Cai), phosphorus (P), magnesium (Mg) and parathyroid hormone (PTH) among others. ClinicalTrials.gov NCT03319680., Results: We included 56 patients, 47 (84%) men and 9 (16%) women, mean age: 65.3 (16.4) years, technique HD/HDF: 20 (35.7%)/36 (64.3%). We found differences (p<0.05) when using the DF with citrate (C) versus acetate (A) in the postdialysis values of bicarbonate [C: 26.9 (1.9) vs. A: 28.5 (3) mmol/L], Cai [C: 1.1 (0.05) vs. A: 1.2 (0.08) mmol/L], Mg [C: 1.8 (0.1) vs A: 1, 9 (0.2) mg/dL] and PTH [C: 255 (172) vs. 148 (149) pg/mL]. We did not find any differences in any of the parameters measured before dialysis. Of the 4,416 sessions performed, 2,208 in each group, 311 sessions (14.1%) with ADF and 238 (10.8%) with CDF (p<0.01), were complicated by arterial hypotension. The decrease in maximum blood volume measured by Hemoscan® biosensor was also lower [-3.4 (7.7) vs -5.1 (8.2)] although without statistical significance., Conclusion: Dialysis with citrate acutely produces less postdialysis alkalemia and significantly modifies Ca, Mg and PTH. CDF has a positive impact on hemodynamic tolerance., (Copyright © 2018 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
19. Statins and antiplatelet agents are associated with changes in the circulatory markers of endothelial dysfunction in chronic kidney disease.
- Author
-
García-Menéndez E, Marques Vidas M, Alique M, Carracedo J, de Sequera P, Corchete E, Pérez García R, Ramírez Chamond R, and Portolés Pérez JM
- Subjects
- Adult, Aged, Biomarkers blood, Cross-Sectional Studies, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Male, Middle Aged, Platelet Aggregation Inhibitors therapeutic use, Renal Insufficiency, Chronic drug therapy, Advanced Oxidation Protein Products blood, Cell-Derived Microparticles drug effects, Endothelium, Vascular physiopathology, Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects, Platelet Aggregation Inhibitors adverse effects, Renal Insufficiency, Chronic blood, Renal Insufficiency, Chronic physiopathology, Vascular Endothelial Growth Factor A blood
- Abstract
Backgrounds and Purposes: Patients with chronic kidney disease (CKD) have higher risk of developing cardiovascular disease. In CKD patients the mechanisms involved in, endothelial damage and the role of different drugs used on these patients are not completely understood. The aim of this work is to analyze the effect of statins and platelet antiaggregant (PA) on endothelial microvesicles (EMVs) and other markers of endothelial dysfunction., Experimental Approach: Cross-sectional study of 41 patients with CKD 3b-4 and 8 healthy volunteers. Circulating levels of EMVs, vascular endothelial growth factor (VEGF), and advance oxidized protein products (AOPPS) were quantified and the correlation with different comorbidity variables and therapeutic strategies were evaluated., Results: EMVs are increased in CKD patients as compared with controls (171.1 vs. 68.3/μl, P<.001). It was observed a negative correlation between age and EMVs. Statins and PA were associated with a reduction in EMVs and VEGF levels, independently of the serum total cholesterol levels (TC). The levels of AOPPS and VEGF were not different in CKD vs. controls., Conclusion: CKD is associated with a change in EMVs, VEGF and AOPP levels. The treatment with statins and PA normalizes these values to almost the observed in controls and this effect is independently of the prevailing TC level. These findings explain the existence of the pleiotropic effects of statins and PA which deserve further studies., (Copyright © 2019 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
20. Unlike Kt, high Kt/V is associated with greater mortality: The importance of low V.
- Author
-
Pérez-García R, Jaldo M, Alcázar R, de Sequera P, Albalate M, Puerta M, Ortega M, Ruiz MC, and Corchete E
- Subjects
- Adult, Aged, Aged, 80 and over, Body Surface Area, Electric Impedance, Female, Follow-Up Studies, Humans, Hyponatremia mortality, Male, Middle Aged, Renal Dialysis methods, Renal Dialysis statistics & numerical data, Retrospective Studies, Time Factors, Young Adult, Body Water, Renal Dialysis mortality, Urea blood
- Abstract
Introduction: Kt/V has been used as a synonym for haemodialysis dose. Patient survival improved with a Kt/V>1; this target was subsequently increased to 1.2 and 1.3. The HEMO study revealed no significant relationship between Kt/V and mortality. The relationship between Kt/V and mortality often shows a J-shaped curve. Is V the confounding factor in this relationship? The objective of this study is to determine the relationship between mortality and Kt/V, Kt and body water content (V) and lean mass (bioimpedance)., Methods: We studied a cohort of 127 prevalent haemodialysis patients, who we followed-up for an average of 36 months. Kt was determined by ionic dialysance, and V and nutrition parameters by bioimpedance. Kt/V, Kt corrected for body surface area (Kt/BSA) and target Kt/BSA were calculated. The mean data from 18,998 sessions were used as haemodialysis parameters, with a mean of 155 sessions per patient., Results: Mean age was 70.4±15.3 years and 61% were male; 76 were dialysed via an arteriovenous fistula and 65 were on online haemodiafiltration. Weight was 70.6 (16.8)kg; BSA 1.8 (0.25) m
2 ; total body water (V) 32.2 (7.41) l and lean mass index (LMI) 11.1 (2.7)kg/m2 . Mean Kt/V was 1.84 (0.44); Kt 56.1 (7)l and Kt/BSA 52.8 (10.4)l. The mean target Kt/BSA was 49.7 (4.5)l. Mean Kt/BSA-target Kt/BSA +6.4 (7.0)l. Patients with a higher Kt/V had worse survival rates than others; with Kt this is not the case. Higher Kt/V values are due to a lower V, with poorer nutrition parameters. LMI and serum albumin were the parameters that best independently predicted the risk of death and are lower in patients with a higher Kt/V and lower V., Conclusion: Kt/V is not useful for determining dialysis doses in patients with low or reduced body water. Kt or the Kt/BSA are proposed as an alternative., (Copyright © 2018 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
21. Asymmetric cellulose triacetate is a safe and effective alternative for online haemodiafiltration.
- Author
-
Albalate Ramón M, Martínez Miguel P, Bohorquez L, de Sequera P, Bouarich H, Pérez-García R, Rodríguez Puyol D, Barril G, Sánchez Tomero JA, Giorgi M, and Ramirez Chamond MR
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Cellulose analogs & derivatives, Hemodiafiltration methods, Membranes, Artificial
- Abstract
Background: In post-dilution haemodiafiltration only synthetic membranes have been used to date. Asymmetric cellulose triacetate (ATA™) is now available, whose characteristics are suitable for this technique., Objectives: To describe the in vivo performance and behaviour of this membrane, to identify its depurative effectiveness, use in clinical practice and its biocompatibility, both acute and after one month of treatment., Methods: Observational prospective study of 23 patients who were dialysed for 4 weeks using an ATA™ membrane and who maintained their prior regimen., Results: A total of 287 sessions were performed and 264 complete sessions were collected. With an effective time of 243.7 (17.6) min and a mean blood flow of 371.7 (23) ml/min, an average Kt of 56.3 (5.3) l was observed, as well as a convection volume of 27.1 (4.2) l, a filtration fraction of 29.9 (3.7) %, a urea reduction ratio (RR) of 81 (5.2) %, a creatinine RR of 74.7 (4.6) %, a β
2 -microglobulin RR of 76.5 (4.8) % and a retinol binding protein RR of 18.6 (7.6) %. There were no technical problems or alarms. Changing the heparin dosage was not necessary. No increases in C3a or C5a concentrations or leukopenia were observed in the first 30min of the session. Neither the monocyte subpopulations nor IL-β1 or IL-6 were significantly altered after one month of treatment., Conclusions: The new ATA™ membrane achieves adequate Kt and convection volume, without technical problems and with good biocompatibility and inflammatory profiles. It is therefore a valid option for post-dilution haemodiafiltration, particularly in patients allergic to synthetic membranes., (Copyright © 2018 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
22. The dialyser in the year 2017: much more than a membrane.
- Author
-
Pérez-García R and Alcázar R
- Subjects
- Adsorption, Equipment Design, Hemodialysis Solutions, Membranes, Artificial, Molecular Weight, Nanotechnology, Porosity, Ultrafiltration, Renal Dialysis instrumentation
- Published
- 2018
- Full Text
- View/download PDF
23. Citrate dialysate does not induce oxidative stress or inflammation in vitro as compared to acetate dialysate.
- Author
-
Pérez-García R, Ramírez Chamond R, de Sequera Ortiz P, Albalate M, Puerta Carretero M, Ortega M, Ruiz Caro MC, and Alcazar Arroyo R
- Subjects
- Acetates adverse effects, Cell-Derived Microparticles drug effects, Cells, Cultured, Dialysis Solutions adverse effects, Dose-Response Relationship, Drug, Humans, Immunocompetence, In Vitro Techniques, Inflammation, Intercellular Adhesion Molecule-1 biosynthesis, Intercellular Adhesion Molecule-1 blood, Leukocytes, Mononuclear metabolism, Monocytes metabolism, Reactive Oxygen Species blood, Renal Dialysis, THP-1 Cells, Uremia blood, Uremia immunology, Uremia therapy, Acetates pharmacology, Citrates pharmacology, Dialysis Solutions pharmacology, Leukocytes, Mononuclear drug effects, Monocytes drug effects, Oxidative Stress drug effects
- Abstract
Increased acetataemia during haemodialysis sessions has been associated with a number of abnormalities, including increased oxidative stress, pro-inflammatory cytokines and nitric oxide synthesis. However, citric acid may play an alternative role to acetate as a dialysate stabiliser given that the effect of citrate on complement and leukocyte activation is different to that of acetate. The purpose of this study was to compare the inflammatory effect in immunocompetent blood cells of acetate dialysate and citrate dialysate., Material and Methods: The effect of acetate and/or citrate was investigated in the whole blood of uraemic patients and in healthy in vitro samples. Four types of dialysate were tested: dialysate 1, acetate-free with 1mmol/L of citrate; dialysate 2, with 0.8mmol/L of citrate and 0.3mmol/L of acetate; dialysate 3, citrate-free with 3mmol/L of acetate; and dialysate 4, citrate-free with 4mmol/L of acetate. The cell types used were: human monocyte culture (THP-1); and peripheral blood mononuclear cells (PBMCs) from healthy subjects and uraemic patients on haemodialysis. ICAM-1 was determined and levels of reactive oxygen species and total microvesicles were quantified., Results: Unlike the citrate dialysates, the dialysates with acetate (dialysate 3 and dialysate 4) induced increased ICAM-1 expression density in THP-1 cells; an increase in ICAM-1 expression was observed in the immunocompetent cells of healthy subjects with acetate dialysate (dialysate 3 and dialysate 4) but not with citrate dialysate (dialysate 1 and dialysate 2). No significant ICAM-1 differences were found between the different dialysates in the cells of haemodialysed patients. Reactive oxygen species expression and the number of microvesicles increased significantly with acetate dialysate but not with citrate dialysate in the cells of both healthy subjects and haemodialysed patients., Conclusions: At the concentrations in which it is generally used in clinical practice, acetate-based dialysate increases oxidative stress and the total number of microvesicles and may induce other pro-inflammatory stimuli typical of uraemic patients on haemodialysis. Citrate dialysates do not induce this activation, which could make them a suitable alternative in clinical practice., (Copyright © 2017 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
24. Calcium mass balance with citrate dialysate is lower than with acetate.
- Author
-
Pérez-García R, Albalate M, Sequera P, and Ortega M
- Subjects
- Acetates administration & dosage, Citrates administration & dosage, Humans, Hypercalcemia etiology, Acetates pharmacology, Calcium metabolism, Citrates pharmacology, Hemodialysis Solutions pharmacology, Hypercalcemia prevention & control, Renal Dialysis
- Published
- 2017
- Full Text
- View/download PDF
25. [Multifactorial program for the prevention of falls: A multifactorial proyect in the rural area].
- Author
-
Pérez García R, González González J, Corregidor Sánchez AI, and Criado Álvarez JJ
- Subjects
- Aged, Aged, 80 and over, Female, Geriatric Assessment, Health Promotion methods, Humans, Male, Pilot Projects, Program Development, Risk Assessment, Spain, Accidental Falls prevention & control, Primary Health Care methods, Rural Health Services
- Published
- 2016
- Full Text
- View/download PDF
26. Guideline for dialysate quality of Spanish Society of Nephrology (second edition, 2015).
- Author
-
Pérez-García R, García Maset R, Gonzalez Parra E, Solozábal Campos C, Ramírez Chamond R, Martín-Rabadán P, Sobrino Pérez PE, Gallego Pereira O, Dominguez J, de la Cueva Matute E, and Ferllen R
- Subjects
- Drug Packaging, Drug Storage standards, Endotoxins analysis, Filtration, Humans, Nephrology, Societies, Medical, Spain, Water Microbiology, Water Pollution, Water Purification, Hemodialysis Solutions standards, Water Quality
- Abstract
A Best Practice Guideline about Dialysis fluid purity was developed under the leadership of the Spanish Society of Nephrology in 2004. The second edition revised Guideline considered new evidences and International Standard. The Guideline has established recommendations for standards for preparing dialysate: water, concentrates and hemodialysis proportioning systems. This Guideline is based on the ISO13959, European Pharmacopoeia, the Real Farmacopea Española, the AAMI Standards and Recommended Practices, European Best Practice Guidelines for Haemodialysis, literature reviews, according to their level of evidence, and the opinion of the expert Spanish group. Two levels of quality of water were defined: purified water and high purified water (ultra pure) and for dialysate: ultra pure dialysate. Regular use of ultra pure dialysate is recommended for all type of hemodialysis to prevent and delay the occurrence of complications: inflammation, malnutrition, anaemia and amiloidosis. Water, concentrates and dialysate quality requirements are defined as maximum allowable contaminant levels: chemicals (4.1.2), conductivity, microbial and endotoxins (4.1.1): Monitoring frequency, maintenance and corrective actions were specified. Methods of sampling and analysis were described in appendix (anexos). For microbiological monitoring, R2A medium is recommended, incubated during 7-14 days at a temperature of 17-23°C. The dialysate quality assurance process involves all dialysis staff members and requires strict protocols. The physician in charge of hemodialysis has the ultimate responsibility for dialysate quality. All suggestions and questions about this Guideline are wellcome to www.senefro.org., (Copyright © 2016 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
27. Hyponatraemia, mortality and haemodialysis: An unexplained association.
- Author
-
Pérez-García R, Palomares I, Merello JI, Ramos R, Maduell F, Molina M, Aljama P, and Marcelli D
- Subjects
- Aged, Cohort Studies, Creatinine, Diabetes Mellitus, Female, Humans, Kidney Failure, Chronic, Male, Prognosis, Sodium, Hyponatremia mortality, Renal Dialysis mortality
- Abstract
Background: As in the general population, in patients on haemodialysis (HD) hyponatraemia is associated with higher mortality risk. The objective of this article was to study the relationship between predialysis serum sodium (sNa) and mortality in an HD population. We also intended to define hyponatraemia and determine the characteristics of hyponatraemic patients in terms of anthropometric data, analytical features, dialysis measurements and hydration (bioimpedance)., Methods: Observational, descriptive study of a cohort of HD incident patients. The independent variable was the mean of each patient's sNa analysed during their first 6 months on HD., Results: A total of 4,153 patients were included in the study. Mean age was 64.7 years; 65.2% of the patients were male and 35% were diabetics. Mean follow-up time was 21.48 (SD) (1.31) months. sNa had a normal distribution, with a mean (SD)=138.46 (2.7) mEq/l. Body weight, diabetes mellitus, systolic blood pressure, interdialytic weight gain, total ultrafiltration, serum glucose, albumin and creatinine, vascular access and haemodialysis type, acquire significant differences between sodium quartiles. Lean tissue index (LTI) in patients with low serum sodium, Q1 (135 mEq/l), was significantly lower than the LTI of patients from the other serum sodium quartiles. Patients with sNa<136 mEq/l had a higher independent mortality risk (OR=1.62) (Cox regression analysis)., Conclusions: HD patients with hyponatraemia patients have a poor prognosis and present malnutrition or fluid overload., (Copyright © 2015 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
28. What is the optimum dialysate flow in post-dilution online haemodiafiltration?
- Author
-
Albalate Ramón M, de Sequera Ortiz P, Pérez-García R, Corchete Prats E, Alcázar Arroyo R, Ortega Díaz M, and Puerta Carretero M
- Subjects
- Adult, Aged, Aged, 80 and over, Conservation of Natural Resources, Costs and Cost Analysis, Cross-Over Studies, Dialysis Solutions economics, Female, Hemodiafiltration economics, Hemodiafiltration instrumentation, Humans, Male, Membranes, Artificial, Middle Aged, Prospective Studies, Water, Dialysis Solutions pharmacokinetics, Hemodiafiltration methods, Kidney Failure, Chronic therapy, Rheology
- Abstract
Introduction: In post-dilution online hemodiafiltration (OL-HDF), the only recommendation concerning the dialysate, or dialysis fluid, refers to its purity. No study has yet determined whether using a high dialysate flow (Qd) is useful for increasing Kt or ultrafiltration-infusion volume., Objective: Study the influence of Qd on Kt and on infusion volume in OL-HDF., Material and Methods: This was a prospective crossover study. There were 37 patients to whom 6 sessions of OL-HDF were administered at 3 different Qds: 500, 600 and 700ml/min. A 5008(®) monitor was used for the dialysis in 21 patients, while an AK-200(®) was used in 17. The dialysers used were: 20 with FX 800(®) and 17 with Polyflux-210(®). The rest of the parameters were kept constant. Monitor data collected were effective blood flow, effective dialysis time, final Kt and infused volume., Results: We found that using a Qd of 600 or 700ml/min increased Kt by 1.7% compared to using a Qd of 500ml/min. Differences in infusion volume were not significant. Increasing Qd from 500ml/min to 600 and 700ml/min increased dialysate consumption by 20% and 40%, respectively., Conclusions: With the monitors and dialysers currently used in OL-HDF, a Qd higher than 500ml/min is unhelpful for increasing the efficacy of Kt or infusion volume. Consequently, using a high Qd wastes water, a truly important resource both from the ecological and economic points of view., (Copyright © 2015 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
29. Acute effect of citrate bath on postdialysis alkalaemia.
- Author
-
Ortiz Pde S, Ramón MA, Pérez-García R, Prats EC, Cobo PA, Arroyo RA, Díaz MO, and Carretero MP
- Subjects
- Acetates administration & dosage, Acetates pharmacology, Acid-Base Imbalance prevention & control, Acidosis etiology, Adult, Bicarbonates administration & dosage, Bicarbonates pharmacology, Blood Gas Analysis, Citrates administration & dosage, Cross-Over Studies, Electrolytes blood, Female, Hemodialysis Solutions administration & dosage, Hemodialysis Solutions chemistry, Humans, Kidney Failure, Chronic blood, Kidney Failure, Chronic therapy, Male, Prospective Studies, Acidosis drug therapy, Citrates pharmacology, Hemodialysis Solutions pharmacology
- Abstract
Introduction: The correction of metabolic acidosis caused by renal failure is achieved by adding bicarbonate during dialysis. In order to avoid the precipitation of calcium carbonate and magnesium carbonate that takes place in the dialysis fluid (DF) when adding bicarbonate, it is necessary to add an acid, usually acetate, which is not free of side effects. Thus, citrate appears as an advantageous alternative to acetate, despite the fact that its acute effects are not accurately known., Objective: To assess the acute effect of a dialysis fluid containing citrate instead of acetate on acid-base balance and calcium-phosphorus metabolism parameters., Material and Methods: A prospective crossover study was conducted with twenty-four patients (15 male subjects and 9 female subjects). All patients underwent dialysis with AK-200-Ultra-S monitor with SoftPac® dialysis fluid, made with 3 mmol/L of acetate and SelectBag Citrate®, with 1 mmol/L of citrate and free of acetate. The following were measured before and after dialysis: venous blood gas monitoring, calcium (Ca), ionic calcium (Cai), phosphorus (P) and parathyroid hormone (PTH)., Results: Differences (p<0.05) were found when using the citrate bath (C) compared to acetate (A) in the postdialysis values of: pH, C: 7.43 (0.04) vs. A: 7.47 (0.05); bicarbonate, C: 24.7 (2.7) vs. A: 27.3 (2.1) mmol/L; base excess (BEecf), C: 0.4 (3.1) vs. A: 3.7 (2.4) mmol/L; corrected calcium (Cac), C: 9.8 (0.8) vs. A: 10.1 (0.7) mg/dL; and Cai, C: 1.16 (0.05) vs. A: 1.27 (0.06) mmol/L. No differences were found in either of the parameters measured before dialysis., Conclusion: Dialysis with citrate provides better control of postdialysis acid-base balance, decreases/avoids postdialysis alkalaemia, and lowers the increase in Cac and Cai. This finding is of special interest in patients with predisposing factors for arrhythmia and patients with respiratory failure, carbon dioxide retention, calcifications and advanced liver disease., (Copyright © 2015. Published by Elsevier España, S.L.U.)
- Published
- 2015
- Full Text
- View/download PDF
30. Clinical, analytical and bioimpedance characteristics of persistently overhydrated haemodialysis patients.
- Author
-
Castellano S, Palomares I, Molina M, Pérez-García R, Aljama P, Ramos R, and Merello JI
- Subjects
- Aged, Aged, 80 and over, Anemia drug therapy, Anemia etiology, Body Composition, Diabetic Nephropathies complications, Diabetic Nephropathies physiopathology, Diabetic Nephropathies therapy, Electric Impedance, Female, Follow-Up Studies, Hematinics therapeutic use, Hemodialysis Solutions administration & dosage, Hemodialysis Solutions adverse effects, Hemodynamics, Humans, Hypotension drug therapy, Hypotension etiology, Kidney Failure, Chronic complications, Kidney Failure, Chronic physiopathology, Kidney Failure, Chronic therapy, Male, Middle Aged, Sodium blood, Water-Electrolyte Imbalance etiology, Renal Dialysis adverse effects, Water-Electrolyte Imbalance physiopathology
- Abstract
Background: Fluid overload is an important and modifiable cardiovascular risk factor for haemodialysis patients. So far, the diagnosis was based on clinical methods alone. Nowadays, we have new tools to assess more objectively the hydration status of the patients on haemodialysis, as BCM (Body Composition Monitor). A Relative Overhydration (AvROH) higher than 15% (it means, Absolute Overhydration or AWOH higher than 2.5 Litres) is associated to greater risk in haemodialysis. However, there is a group of maintained hyperhydrated patients. The aim of the present study is to identify the characteristics of patients with maintained hyperhydrated status (AvROH higher than 15% or AWOH higher than 2.5 liters). The secondary aim is to show the hemodynamic and analytical changes that are related to the reduction in hyperhydration status., Methods: Longitudinal cohort study during six months in 2959 patients in haemodialysis (HD) that are grouped according to their hydration status by BCM. And we compare their clinical, analytical and bioimpedance spectroscopy parameters., Results: The change in overhydration status is followed by a decrease in blood pressure and the need for hypotensive drugs (AHT) and erythropoiesis stimulating agents (ESA). The target hydration status is not reached by two subgroups of patients. First, in diabetic patients with a high comorbidity index and high number of hypotensive drugs (AHT) but a great positive sodium gradient during dialysis sessions; and, younger non-diabetic patients with longer time on hemodialysis and positive sodium gradient, lower fat tissue index (FTI) but similar lean tissue index (LTI) and albumin than those with a reduction in hyperhydration status., Conclusion: Those patients with a reduction in hyperhydration status, also show a better control in blood pressure and anemia with less number of AHT and ESA. The maintained hyperhydrated patients, diabetic patients with many comorbidities and young men patients with longer time on hemodialysis and non-adherence treatment, can profit from a constant monitoring of their hydration state as well as an individualized treatment (dialysis and drugs).
- Published
- 2014
- Full Text
- View/download PDF
31. Psychosocial factors and adherence to drug treatment in patients on chronic haemodialysis.
- Author
-
Huertas-Vieco MP, Pérez-García R, Albalate M, de Sequera P, Ortega M, Puerta M, Corchete E, and Alcázar R
- Subjects
- Anxiety etiology, Cognition Disorders etiology, Comorbidity, Cross-Sectional Studies, Depression etiology, Diabetic Nephropathies drug therapy, Diabetic Nephropathies psychology, Diabetic Nephropathies therapy, Humans, Kidney Failure, Chronic drug therapy, Kidney Failure, Chronic therapy, Polypharmacy, Psychology, Quality of Life, Self Report, Severity of Illness Index, Social Support, Spain, Kidney Failure, Chronic psychology, Medication Adherence, Renal Dialysis psychology
- Abstract
Background: The daily pill burden in hemodialysis patients is one of the highest reported to date in any chronic disease. The adherence to prescribed treatment has implications on the quality of life, the survival of patients, and the economic cost of their treatment, this being a priority public health issue., Objective: To evaluate the adherence to pharmacological treatment examining, among the possible causes of non-adherence, psychosocial factors such as depression, anxiety, cognitive impairment and social support., Method: Transversal-observational study of thirty five patients that suffer from chronic renal disease and who are on manteinance hemodialysis, evaluated by self-reported measures., Results: Non-adherent patients have significant higher depression index than adherent patients. Anxiety, cognitive impairment and social support do not show a significant relation with the degree of adherence or compliance with farmacological treatment., Conclusions: These results suggest that psychological intervention in chronic haemodialysis patients with a severe depression index could increase the degree of fulfillment and general well-being of renal patients.
- Published
- 2014
- Full Text
- View/download PDF
32. Hyperkalaemia in hospitalised patients. How to avoid it?
- Author
-
de Sequera P, Alcázar R, Albalate M, Pérez-García R, Corchete E, Asegurado P, Puerta M, and Ortega-Díaz M
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Humans, Hyperkalemia epidemiology, Male, Middle Aged, Young Adult, Hospitalization, Hyperkalemia prevention & control
- Published
- 2014
- Full Text
- View/download PDF
33. On-line haemodiafiltration after the ESHOL study.
- Author
-
Pérez-García R
- Subjects
- Humans, Randomized Controlled Trials as Topic, Hemodiafiltration methods, Online Systems
- Published
- 2014
- Full Text
- View/download PDF
34. A comparison of the effectiveness of two online haemodiafiltration modalities: mixed versus post-dilution.
- Author
-
de Sequera P, Albalate M, Pérez-García R, Corchete E, Puerta M, Ortega M, Alcázar R, Talaván T, and Ruiz-Álvarez MJ
- Subjects
- Adult, Aged, Aged, 80 and over, Albumins analysis, Blood Pressure, Blood Proteins analysis, Convection, Cross-Over Studies, Dialysis Solutions chemistry, Female, Hematocrit, Humans, Male, Middle Aged, Molecular Weight, Nephelometry and Turbidimetry, Prospective Studies, Renal Insufficiency, Chronic blood, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic therapy, Retinol-Binding Proteins analysis, Uremia blood, Uremia etiology, beta 2-Microglobulin analysis, Hemodiafiltration methods, Uremia therapy
- Abstract
Introduction: Haemodiafiltration (HDF) with high reinfusion volumes is the most effective technique for clearing uraemic toxins. There are various modalities depending on the location where the replacement volume is administered in the extracorporeal circuit: pre-dilution, mixed or mid-dilution and post-dilution, in which the infusion is carried out pre-dilution, pre- and post-dilution simultaneously and post-dilution, respectively., Objective: Compare the clearance of small, medium-sized and protein-bound molecules and the convective volume administered in online HDF (OL-HDF) in post-dilution and mixed (pre-post-dilution) infusion., Material and Method: A prospective, randomised, crossover study comparing post-dilution and mixed OL-HDF. Patients (n=8) were randomly assigned to receive 6 sessions in each technique. We conducted 89 sessions, of which 68 were at a scheduled time (ST) and 21 at an effective time (ET). We determined the reduction rate (RR) percentages for various substances and the infusion volumes. The RR study was performed using ET., Results: The KT value obtained was greater with post-dilution OL-HDF [68 (8.1) compared to 64.9 (8.8) litres] (P=.009) when patients were dialysed at ST. This difference disappeared when dialysis was performed at ET. The difference between ST and ET was greater in mixed HDF than in post-dilution HDF [10.3 (7.4) compared to 6.5 (3.1) minutes, P=.02]. We found no differences in the RR of the substances analysed., Conclusion: Mixed OL-HDF is not inferior to post-dilution OL-HDF either in the clearance of small and medium-sized molecules or in the clearance of protein-bound molecules at the same ET.
- Published
- 2013
- Full Text
- View/download PDF
35. Sodium set-point in haemodialysis: is it what we see clinically?
- Author
-
Albalate Ramón M, de Sequera Ortiz P, Pérez-García R, Ruiz-Álvarez MJ, Corchete Prats E, Talaván T, Alcázar Arroyo R, Puerta Carretero M, and Ortega-Díaz M
- Subjects
- Adult, Aged, Aged, 80 and over, Blood Glucose analysis, Body Water, Diabetic Nephropathies blood, Diabetic Nephropathies therapy, Dialysis Solutions analysis, Electric Conductivity, Female, Follow-Up Studies, Humans, Kidney Failure, Chronic blood, Kidney Failure, Chronic therapy, Male, Middle Aged, Plethysmography, Impedance, Potentiometry methods, Retrospective Studies, Water-Electrolyte Imbalance blood, Water-Electrolyte Imbalance etiology, Weight Gain, Young Adult, Renal Dialysis adverse effects, Sodium blood
- Abstract
Background: Natraemia in haemodialysis (HD) patients is considered constant contrary to daily clinical observations. Its relationship with clinical parameters, dialysis parameters and body water (BW) distribution is not clear., Objectives: The aims of this study were to know 1) the intraindividual variability of natraemia, 2) the relationship between natraemia and clinical and dialysis parameters and 3) the relationship between natraemia and BW distribution by bioimpedance., Material and Method: Observational retrospective study on 98 chronic HD patients. Clinical, HD and natraemia, glucose and bioimpedance data were collected., Results: We included 63 males and 35 females of 69.6 (21-91) years of age, with a follow-up of 23.2 (10) months. Variability: 1802 sodium measurements: mean natraemia 138 (3.2) mEq/l and corrected for glucose: 139.1 (3.6) mEq/l, p<.0001. Intraindividual coefficient of variation (CV) was 2% (0.8) (range 1-5.6%) and it correlated negatively with natraemia (r=-0.63, p<.0001). Clinical parameters: corrected natraemia was lower in diabetics than in non-diabetics 138 (2.4) compared with 139 (2) mEq/l, p<.003, CV 2.3 (0.9) compared with 1.9 (0.7)% (p<.01) and SD 3.2 (1.2) compared with 2.5 (0.9) mEq/l (p<.04). No differences according to gender, age, HD time, cardiac or liver disease, medication use, residual renal function or mortality were found. HD parameters: a positive relationship was found between natraemia and total dialysate conductivity and it was negative with interdialysis weight gain (IDG). - Bioimpedance: no relationship was found between natraemia and BW distribution., Conclusions: Natraemia varies in each patient and is related positively with conductivity and negatively with IDG. In diabetics natraemia is lower and CV is higher. There is no relationship between natraemia and BW distribution.
- Published
- 2013
- Full Text
- View/download PDF
36. Improvement of therapeutic compliance in haemodialysis patients with poor phosphorus control and adherence to treatment with binders: COMQUELFOS study.
- Author
-
Dolores Arenas M, Pérez-García R, Bennouna M, Blanco A, Mauricio O, Prados MD, Lerma JL, Luisa Muñiz M, and Belén Martín M
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Surveys and Questionnaires, Young Adult, Chelating Agents therapeutic use, Hyperphosphatemia drug therapy, Medication Adherence statistics & numerical data, Phosphorus metabolism, Renal Dialysis
- Abstract
Background: The effectiveness of phosphate binders in daily practice is directly related to therapeutic compliance (TC) by the patient. The goal of this study was to analyse the TC of haemodialysis patients with hyperphosphatemia and its influence on serum phosphorus for 6 months follow up., Methods: 181 patients were included, who had mean initial phosphate levels (P) >5mg/dl. TC with different phosphate binders was evaluated, considering non-adherent patients those who had <75% of TC, SMAQ scale score of "non-adherent"(Table 1), and P>5mg/dl. Patients who were adherent at baseline visit (BV) left the study, the rest continued to V5 (6 months). TC at baseline and during the follow up (V1-V5) was analysed. Phosphate binders and the evolution of phosphataemia based on treatment were assessed., Results: 103 male and 78 female patients were evaluated, with a mean age of 59.9 (21-86) years. Of these, 39.2% (n=71) were adherent in the BV. Patients older than 60 years of age were more adherent than younger ones (P=.019).Table 6 specifies the causes of non-compliance. The remaining 60.8% of patients (n=110), were non-adherent and continued through to the end of the study. An average of 27.2% of these patients became adherent during the course of the study. Table 7 shows the relative levels of P with TC over successive visits. At the end of the study, mean P levels had decreased by 1.26mg/dl (P<.0001)., Conclusion: Among HD patients with poor P level control, there is a low level of adherence with phosphorus binder treatment, at 39.2%. Compliance and phosphataemia are improved with different strategies. The decrease of P is higher in adherent patients than in non-adherent patients.
- Published
- 2013
- Full Text
- View/download PDF
37. On-line haemodiafiltration improves response to calcifediol treatment.
- Author
-
Pérez-García R, Albalate M, de Sequera P, Alcázar R, Puerta M, Ortega M, and Corchete E
- Subjects
- Aged, Calcifediol adverse effects, Calcifediol blood, Calcium blood, Cohort Studies, Diabetic Nephropathies complications, Female, Humans, Hypercalcemia chemically induced, Kidney Failure, Chronic blood, Kidney Failure, Chronic complications, Male, Middle Aged, Parathyroid Hormone blood, Phosphorus blood, Prospective Studies, Vitamin D Deficiency blood, Vitamin D Deficiency complications, Calcifediol therapeutic use, Hemodiafiltration, Kidney Failure, Chronic therapy, Vitamin D Deficiency drug therapy
- Abstract
Introduction: 25-hydroxy vitamin D (25-OH-vit D) levels in the blood are associated with multiple pathologies. "Normal" values have been defined based on cardiovascular risk, and under this framework, patients with chronic kidney disease often have a deficit. 25-OH-vit D replacement in patients on haemodialysis (HD), in which dosage has not yet been clearly established, is becoming a constant in our daily practice., Objective: To assess whether dialysis technique influences the baseline concentration of 25-OH-vitamin D and the response to supplements., Method: Prospective observational study of two cohorts of patients, those patients treated with calcifediol and those untreated (controls). Blood levels of Ca, P, PTH, and 25-OH-vit D were measured in 59 prevalent patients on HD (35 male; mean age: 65.2 (15.7) years) in November 2010. Thirty-six patients with 25-OH-vit D<10 ng/ml were treated with weekly calcifediol (Hidroferol®, 1 ampoule: 266 μg) since January 2011, which was administered after HD by a nurse. They received 6 doses, and blood levels were measured again in March 2011. We compared the response based on the technique of HD (online haemodiafiltration [OL-HDF] vs HD)., Results: Mean baseline values (n=59): 25-OH-vit D: 9.8 (7.0)ng/ml, Ca: 9.3 (0.5)mg/dl, P: 4.5 (1.4)mg/dl, and iPTH: 299 (224)pg/ml. There were no differences by age, sex, or dialysis technique (HD vs OL-HDF). Treated patients (n=36): 25-OH-vit D levels rose from 6.2 (3.4)ng/ml to 51 (22.9)ng/ml (P<.0001), without significant changes in Ca. Serum phosphate increased an average of 0.6 (1.4)mg/dl, from 4.4 mg/dl to 5mg/dl, (P=.015). PTH decreased an average of 85 (208)pg/ml (P=.023). In these patients, the indication for phosphate binders increased by an average dose equivalent of 0.47 (0.82)mg/dl (P<.001). The 13 patients under treatment with OL-HDF reached 25-OH-vit D levels significantly higher than the 23 treated on HD: 63 (21)ng/ml vs 43 (21)ng/ml (P=.011). Dual treatment with native and active Vit D was associated with significantly increased levels of P (P=.043). Untreated patients (n=23): 25-OH-vit D levels decreased from 15.3 (7.5)ng/ml in November to 11.1 (6.8)ng/ml in March (P<.01), without significant changes in P or PTH and without differences according to age. 25-OH-vit D levels declined in patients on HD (15) but not in patients on OL-HDF., Conclusion: The patients on haemodialysis have low or very low baseline values for 25-OH-vit D. The response to treatment with calcifediol is good, with the most marked improvement occurring in patients on OL-HDF. Furthermore, 25-OH-vit D levels decreased in untreated patients, which was probably correlated with the lower sun exposure in winter. Some patients experienced an increase in phosphataemia despite increasing the dosage of phosphate binders, mainly in those receiving treatment with active vitamin D.
- Published
- 2012
- Full Text
- View/download PDF
38. Spanish study of anticoagulation in haemodialysis.
- Author
-
Herrero-Calvo JA, González-Parra E, Pérez-García R, and Tornero-Molina F
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Drug Utilization statistics & numerical data, Female, Humans, Male, Middle Aged, Spain, Young Adult, Anticoagulants therapeutic use, Renal Dialysis
- Abstract
Objectives: This study’s objectives were to determine which anticoagulation methods are commonly used in patients who are undergoing haemodialysis (HD) in Spain, on what criteria do they depend, and the consequences arising from their use., Material and Method: Ours was a cross-sectional study based on two types of surveys: a "HD Centre Survey" and a "Patient Survey". The first survey was answered by 87 adult HD units serving a total of 6093 patients, as well as 2 paediatric units. Among these units, 48.3% were part of the public health system and the remaining 51.7% units were part of the private health system. The patient survey analysed 758 patients who were chosen at random from among the aforementioned 78 HD units., Results: A) HD Centre Survey: The majority of adult HD units (n=61, 70.2%) used both kinds of heparin, 19 of them (21.8%) only used LMWH and 7 of them (8%) only used UFH. The most frequently applied criteria for the use of LMWH were medical indications (83.3% of HD units) and ease of administration (29.5%). The most frequently used methods for adjusting the dosage were clotting of the circuit (88.2% of units), bleeding of the vascular access after disconnection (75.3%), and patient weight (57.6%). B) Patient Survey: The distribution of the types of heparin used was: UFH: 44.1%, LMWH: 51.5%, and dialysis without heparin in 4.4% of patients. LMWH was more frequently used in public medical centres (64.2% of patients) than in private medical centres (46.1%) (P<.001). LMWH was more frequently used in on-line haemodiafiltration (HF) than in high-flux HD (P<.001). Antiplatelet agents were given to 45.5% of patients, oral anticoagulants to 18.4% of patients, and both to 5% of patients. Additionally, 4.4% of patients had suffered bleeding complications during the previous week, and 1.9% of patients suffered thrombotic complications. Bleeding complications were more frequent in patients with oral anticoagulants (P=.001), although there was no association between the type of heparin and the occurrence of bleeding or thrombotic complications., Conclusions: We are able to conclude that there is a great amount of disparity in the criteria used for the medical prescription of anticoagulation in HD. It is advisable that each HD unit revise their own results as well as those from other centres, and possibly to create an Anticoagulation Guide in Haemodialysis.
- Published
- 2012
- Full Text
- View/download PDF
39. Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD® database: results from years 2009-2010.
- Author
-
Pérez-García R, Palomares-Sancho I, Merello-Godino JI, Aljama-García P, Bustamante-Bustamante J, Luño J, Maduell-Canals F, Martín-de Francisco AL, Martín-Malo A, Mirapeix-i-Vicens E, Molina-Núñez M, Praga-Terente M, Tetta C, and Marcelli D
- Subjects
- Adolescent, Adult, Aged, Databases, Factual, Epidemiologic Studies, Female, Health Facilities, Humans, Male, Middle Aged, Spain, Time Factors, Young Adult, Renal Dialysis, Renal Insufficiency, Chronic therapy
- Abstract
Observational study of patients on hemodialysis (HD) in FMC® Spain clinics over the years 2009 and 2010. The data were collected from the EuClid® database, implemented in the clinics of FMC®, which complies with the following feature: record online, compulsory, conducted in patients incidents and that it covers the entire population on HD in these clinics. Its aim is to understand the characteristics of patients and treatment patterns, comparing them with other studies described in the literature and in order to improve their prognosis and quality of life. Include 2637 incidents patients and 4679 prevalent, which makes a total of 7316 patients. In prevalent patients: 24.4% were diabetic; 76.3% had cardio-vascular disease (CVD) and 13.4% cancer. Among the incidents, these percentages were: 33.5% diabetic; 80.6% had CVD and 12.6% cancer. The prevalent patients had such as vascular access: FAV 68.5%, prosthesis 5.6%, permanent catheter 23.7% and 2.3% temporary catheter. The average of the duration of the sessions of HD was 230 minutes. 23.2% of the prevalent patients were on on-line hemodiafiltration. These patients hospitalization rates were 0.46 hospitalizations per incident patient per year and 0.52 per prevalent patient per year. The annual gross mortality rate was 12%. The mortality of the patients in this study HD is smaller than these of the Spanish Registry of Dialysis and Transplant (GRER). The result of morbidity and mortality of the FMC clinics of Spain can, therefore, be as good compared with these of the GRER and other international series. That does not mean that there are not areas of improvement as the increase in the time of dialysis, the percentage of patients on on-line hemodiafiltration convective techniques and the percentage of FAV.
- Published
- 2012
- Full Text
- View/download PDF
40. Adult onset Hallervorden-Spatz disease with psychotic symptoms.
- Author
-
del Valle-López P, Pérez-García R, Sanguino-Andrés R, and González-Pablos E
- Subjects
- Adult, Humans, Male, Pantothenate Kinase-Associated Neurodegeneration complications, Pantothenate Kinase-Associated Neurodegeneration diagnosis, Psychotic Disorders etiology
- Abstract
Hallervorden-Spatz disease is a rare neurological disorder characterized by pyramidal and extrapyramidal manifestations, dysarthria and dementia. Its onset is usually in childhood and most patients have a fatal outcome in few years. A high percentage of cases are hereditary with a recessive autosomal pattern. In the majority of the patients reported, a mutation of the gene that encodes the pantothenate kinase (PANK2) located in the 20p13-p12.3 chromosome that causes iron storage in the basal ganglia of the brain has been found. Its diagnosis is based on clinical symptoms as well as specific MRI imaging findings. The most common psychiatric features are cognitive impairment as well as depressive symptoms. There are few documented cases with psychotic disorders. We present the case of a patient with late onset Hallervorden-Spatz disease and psychotic symptoms that preceded the development of neurological manifestations. The pathophysiology and the treatment of psychotic symptomatology are presented and discussed. Key words: Psicosis, Hallervorden-Spatz, late onset, Basal ganglia.
- Published
- 2011
41. Clinical application of Ultracontrol®: infusion volume and use with different dialyzers.
- Author
-
Albalate Ramón M, Pérez García R, de Sequera Ortiz P, Alcázar Arroyo R, Corchete Prats E, Puerta Carretero M, Ortega Díaz M, and Mosse A
- Subjects
- Aged, Automation, Clinical Alarms, Equipment Design, Female, Hemodialysis Solutions pharmacokinetics, Humans, Male, Manometry instrumentation, Middle Aged, Rheology, Survival Rate, Hemodiafiltration instrumentation, Kidney Failure, Chronic therapy, Renal Dialysis instrumentation
- Abstract
Introduction: Recent studies indicate that the survival benefit with post-dilution on line hemodiafiltration (OL-HDF-post) are achieved if the infusion volume (Vinf) is greater than 20L per session, a goal that is not easily achieved due to hemoconcentration problems. Today we have automated techniques to achieve higher performance minimizing the number of alarms as Ultracontrol® (Ultrac). The objective in the first part of study was to evaluate the UltraC performance (expressed as the filtration fraction (FF) and Vinf) and which problems it presents, and in the second part, to study its performance with four different dialyzers., Material and Methods: 1st period. Nine patients were transferred to OL-HDF-post with UltraC. The first 3 months on OL-HDF all sessions were recorded and compared with hemodialysis sessions in the previous month. 2nd part: 18 patients on chronic OL-HDF-post were dialyzed for a week with each of these dialyser: FX1000, FX800, Elisio210H and Polyflux210., Results: 1st period: In 3 patients, problems associated with inappropriate pressures emerged. In 3 patients there were problems associated with inadequate PTM and Psist that resolved changing to pressure control. Mean values were: maximum Qb 441 (21) (range 350-490) ml/min, Vinf 26.3 (3.3) l/session, FF 30.6 (2.5)%, KT 59.9 (5) l/session. KT increase of 12% compared to HD. 2nd part: Polyflux210 required less UltraC withdrawals than the others. Different PTM or Psist were found and determined the need for removal of the system. The KT was adequate. a) The UltraC system reaches FF of 30% with minimal alarms and Vinf higher than 20 l. b) Structural characteristics of dialysers can limit their use with UltraC although they managed to desirable KT and Vinf in a manual way.
- Published
- 2011
- Full Text
- View/download PDF
42. [Have we forgotten the most important thing to prevent bacteremias associated with tunneled hemodialysis catheters?].
- Author
-
Albalate, Pérez García R, de Sequera P, Alcázar R, Puerta M, Ortega M, Mossé A, and Crespo E
- Subjects
- Bacteremia epidemiology, Bacteremia etiology, Catheter-Related Infections epidemiology, Catheter-Related Infections etiology, Fever etiology, Guideline Adherence, Hospital Units statistics & numerical data, Humans, Renal Dialysis nursing, Retrospective Studies, Spain epidemiology, Universal Precautions, Bacteremia prevention & control, Catheter-Related Infections prevention & control, Catheters, Indwelling adverse effects, Renal Dialysis instrumentation
- Abstract
Bacteremia associated with tunneled central venous catheters (CVC) is a major complication in hemodialysis patients. Strategies that aim to prevent catheter-related bacteremia (CRB), ranging from the application of topical antibiotics to the use of different catheter-lock solutions, have been studied, but limited interest has been shown about following standardization of aseptic care and maintenance of CVC by experienced staff. This study reports CRB incidence obtained with a strict infection prophylaxis protocol based on universal precautions against infection adopted in our Unit by qualified nursing hemodialysis staff. During a period of 20 months, 32 patients received 42 CVC. There were 2 CRB, with an incidence of 0.24 CRB/1000 days-catheter. This study shows that an optimal catheter-use management reduces the incidence of CRB to excellent rates. The use of a protocol directed to vigorously protect the catheter at the time of usage by specialized teams is critically important and is highly recommended.
- Published
- 2010
- Full Text
- View/download PDF
43. [Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance].
- Author
-
Coll E, Pérez-García R, Martín de Francisco AL, Galcerán J, García-Osuna R, Martín-Malo A, Martínez-Castelao A, Sánchez B, Llopis R, and Alvarez de Lara MA
- Subjects
- Acetates adverse effects, Adult, Aged, Aged, 80 and over, Bicarbonates administration & dosage, Bicarbonates pharmacology, Body Weight, Chlorides blood, Female, Hemodialysis Solutions adverse effects, Humans, Hypotension chemically induced, Hypotension epidemiology, Incidence, Kidney Failure, Chronic blood, Kidney Failure, Chronic therapy, Male, Middle Aged, Renal Dialysis, Young Adult, Acetates blood, Hemodiafiltration methods, Hemodialysis Solutions pharmacokinetics, Hemodynamics drug effects
- Abstract
Summary Background: The small quantity of acetate present in the dialysis fluid exposes patient's blood to an acetate concentration 30-40 times the physiological levels. This amount is even greater in hemodiafiltration on-line. Our purpose was to evaluate the clinical-analytical effects using three different dialysis techniques in the same patient., Methods: 35 patients on hemodialysis were included. All patients were treated with conventional bicarbonate dialysate for 3 months, after randomization were switched to first be treated with PHF online with standard bicarbonate dialysate for 6 months and then switched to PHF on-line acetate-free dialysate for the other 6 months or to invert the two last periods. Blood samples were drawn monthly throughout the study and clinical data were obtained., Results: Postdialysis blood acetate levels were higher in patients treated with conventional bicarbonate dialysate with respect to the period of PHF with free-acetate dialysate. Moreover, the percentage of patients with postdialysis blood acetate levels in the pathologic range was higher in patients treated with conventional bicarbonate dialysate respect to PHF on-line acetate-free dialysate period (61% vs. 30%). Serum concentrations of chloride postdialysis were higher and serum concentrations of bicarbonate pre and posthemodialysis were lower in the PHF free-acetate period. The incidence of hypotensive episodes was significantly lower in the PHF on-line with conventional dialysate., Conclusions: PHF on-line with free-acetate dialysate allows that most of patients finished hemodialysis with blood acetate levels in the physiologic ranges. PHF on-line is a predilutional hemodiafiltration treatment with better tolerance than hemodialysis with standard bicarbonate dialysate.
- Published
- 2009
- Full Text
- View/download PDF
44. [The essential role of water treatment system (WTS) in the qualify of water for hemodialysis].
- Author
-
Pérez-García R
- Subjects
- Hemodialysis Solutions standards, Renal Dialysis, Water standards, Water Purification standards
- Published
- 2008
45. [Peripheral vascular disease: prevalence, mortality and relationship with inflammation in hemodialysis].
- Author
-
Vega A, Pérez García R, Abad S, Verde E, López Gómez JM, Jofré R, Puerta M, and Rodríguez P
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Inflammation etiology, Male, Middle Aged, Prevalence, Retrospective Studies, Peripheral Vascular Diseases epidemiology, Peripheral Vascular Diseases etiology, Peripheral Vascular Diseases mortality, Renal Dialysis adverse effects
- Abstract
Peripheral vascular disease (PVD) is a common disease among patients undergoing hemodialysis leading to increase morbidity and mortality with a high risk of inflammation and sepsis. The aim of the present study was to determinate PVD prevalence in our hemodialysis population and association with inflammation. The study sample consisted of 220 patients prevalents in hemodialysis. A basal study was made in 2001 and a follow up for 47 months. Data were collected retrospectively. PVD diagnosis was made attending to limb pulses and doppler in revisions. Diagnosis was classified as rest pain, ischemic ulceration and gangrene. Among a total of 220 patients, 89 had prevalent PVD. Thirty per cent had rest pain, 6,5% had ischemic ulceration and 3% had gangrene. Ninety five per cent underwent medical treatment, 0,5% were treated by percutaneous transluminal angioplasty (PTA), 2% were treated with surgical revascularization and 2,5% were treated with amputation. Patients with PVD were older, with higher Charlson index, diabetes, they hay higher CRP and fibrinogen serum levels; and lower albumin and prealbumine serum levels. Survival PVD was decreased in Kaplan-Meier (log rank =12,4; p<0,000). Adjusted Cox regression analysis revealed that PVD (p =0,034; OR =2,10; IC [1,06 ; 4,23]) ; age (p =0,001; OR =1,06; IC [1,03 ; 1,09]) and low serum albumin levels (p =0,012; OR =0,93; IC [0,89 ; 0,98]) predicted significantly the risk of mortality. PVD is an independent mortality risk factor in hemodialysis patients. An early diagnosis and treatment are able with examination and doppler. In our sample, a few patients are treated with PTA or surgical revascularization. There is an association between PVD and inflammation.
- Published
- 2008
46. [Gastrointestinal stromal tumors. Report of two cases].
- Author
-
Pérez-García R and Xochipostequi-Muñoz CA
- Subjects
- Adult, Female, Humans, Gastrointestinal Stromal Tumors pathology
- Abstract
Objective: We undertook this study to describe two cases of intestinal gistoma histologically and immunochemically proven., Clinical Cases: The study took place at a third level health care hospital in Mexico. Case 1. We report the case of a 39-year-old female with 4 years evolution of lower abdominal pain and with a 16-cm tumoral mass. The patient reported a 28-kg weight loss during the previous 6 weeks. Ultrasound revealed a left adnexal mass (12 x 17 x 15 cm) and CA125 tumor marker value of 4 ng/ml. Laparotomy identified a 15-cm intestinal mass with metastasis to mesentery, diaphragm and bladder. Palliative resection was performed of the small bowel, intestinal mass and termino-terminal anastomosis. The patient was referred to the Medical Oncology Department for adjuvant treatment. Case 2. We report the case of a 37-year-old female with digestive hemorrhage (hematoquezy) during a period of 3 years who needed a blood transfusion on several occasions. The most recent transfusion was 2 days prior to her hospitalization. Physical examination did not reveal any abnormalities; hemoglobin was 8.3 g/dl, platelets 135,000/dl and white blood cells 8.8/dl. Patient had a normal panendoscopy and colonoscopy. Abdominopelvic ultrasound revealed polycystic ovaries, technetium-99 nuclear scan revealed the presence and persistence of Meckel diverticulum. Laparotomy showed intestinal mass of 5 x 5 cm, 70 cm from Treitz angle. We used a wide intestinal resection, proximal and distal from the mass and termino-terminal anastomosis. Histochemical study was CD34 positive. The patient was asymptomatic 3 months postoperatively., Conclusion: Gistomas are tumors of the gastrointestinal tract that are difficult to diagnosis because they are located in the submucosa. Treatment for primary tumor is surgical. Treatment for recurrent or metastatic GIST is imatinib or, if the patient is allergic to imatinib, another new tyrosine kinase inhibitor such as subitinib may be used. Definitive diagnosis is made by immunohistochemistry against CD117, and CD34, in the same manner as our cases.
- Published
- 2007
47. [Colorectal cancer. Measures of prevention].
- Author
-
Pérez-García R
- Subjects
- Adenomatous Polyposis Coli complications, Adult, Alcohol Drinking adverse effects, Biomarkers, Child, Colitis, Ulcerative complications, Colonoscopy, Colorectal Neoplasms diagnosis, Colorectal Neoplasms epidemiology, Colorectal Neoplasms genetics, Colorectal Neoplasms, Hereditary Nonpolyposis complications, Crohn Disease complications, Diet, Genetic Markers, Humans, Mexico epidemiology, Middle Aged, Occult Blood, Primary Prevention, Risk Factors, Sigmoidoscopy, Smoking adverse effects, Colorectal Neoplasms prevention & control
- Published
- 2007
48. [Resistance index to epoetin alpha and to darbepoetin-alpha in chronic hemodialysis patients: a cohort study].
- Author
-
Pérez-García R, Rodríguez Benítez P, Jofre R, López-Gómez JM, Villaverde MT, Blanco A, Blanco S, and Sánchez M
- Subjects
- Adult, Aged, Anemia prevention & control, C-Reactive Protein metabolism, Cohort Studies, Darbepoetin alfa, Epoetin Alfa, Female, Humans, Male, Middle Aged, Prospective Studies, Recombinant Proteins, Renal Insufficiency, Chronic therapy, Erythropoiesis, Erythropoietin administration & dosage, Erythropoietin analogs & derivatives, Hematinics administration & dosage, Hemoglobins metabolism, Renal Dialysis
- Abstract
The effectiveness of the erythropoietic response can be evaluated using the resistance index (RI) to erythropoietic agents (EA) that measures the relationship between the dose administered and the hemoglobin levels attained. In a hemodialysis population, the RI is associated with several clinical and biochemical parameters, such as albumin levels, C-reactive protein (CRP), body mass index (BMI) and Kt/V. This index therefore reflects an important group of parameters that indicate comorbidities and measures the effectiveness of the treatment received. A substantial proportion of chronic hemodialysis patients show a relative resistance to human recombinant erythropoietin (rHuEPO) and require high doses to reach hemoglobin levels above 11 g/dl. Darbepoetin alpha is a new erythropoietic agent with a longer half-life than rHuEPO and greater biological activity in vivo. Furthermore, it remains at clinically effective plasma levels for much longer than rHuEPO. This study evaluated the effect on RI of switching from epoetin alpha to darbepoetin alpha in hemodialysis patients requiring i.v. rHuEPO at either high ( >10,000 UI/w) or low ( <4,000 UI/w) doses, compared to a control group receiving epoetin alpha. Unlike the control group, both groups of patients who switched to darbepoetin alpha showed a reduction in RI and a progressive reduction in the dose required of darbepoetin alpha with respect to the equivalent dose at treatment conversion. In the group requiring high doses, darbepoetin alpha RI (DRI) at week 24 was a significant 23.9% lower than epoetin alpha RI (ERI) at conversion (week 0) (p <0.01). In the group requiring low doses, DRI at week 24 was 13.4% lower than the ERI at conversion (p = NS). In both control groups, ERI at week 24 was higher than ERI at week 0. All groups showed stable hemoglobin levels across the study, with mean levels between 11.5 and 13.3 g/dl. CRP at week 24 was significantly related to albumin levels (p <0.001). In conclusion, switching hemodialysis patients from epoetin alpha to darbepoetin alpha was associated with a significant improvement in RI in the group of patients with high doses of EA, which we consider to be an important indicator of the effectiveness and quality of the treatment administered.
- Published
- 2007
49. [From renal osteodistrophy to bone and mineral metabolism lesions associated to renal chronic disease].
- Author
-
Lorenzo V, Rodríguez Portillo M, Pérez García R, and Cannata JB
- Subjects
- Chronic Disease, Humans, Bone and Bones metabolism, Chronic Kidney Disease-Mineral and Bone Disorder complications, Chronic Kidney Disease-Mineral and Bone Disorder metabolism, Kidney Diseases complications, Kidney Diseases metabolism, Minerals metabolism
- Published
- 2007
50. [Clinical and analytical changes in hemodialysis without acetate].
- Author
-
Coll E, Pérez-García R, Rodríguez-Benítez P, Ortega M, Martínez Miguel P, Jofré R, and López-Gómez JM
- Subjects
- Acetates blood, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Kidney Failure, Chronic blood, Kidney Failure, Chronic therapy, Renal Dialysis
- Abstract
Background: the purpose of this study was to evaluate blood acetate levels and its correlation with clinical and analytical changes in hemodialysis patients treated with standard bicarbonate dialysate compared to treatment with acetate-free bicarbonate dialysate., Methods: fourteen patients on hemodialysis (11 male) with mean age of 61 15 years, were treated with conventional bicarbonate dialysate for 1 month and then switched to acetate-free bicarbonate dialysate for another month. Blood samples were drawn at the third session of first and fourth week of each type of dialysis., Results: Pre-dialysis blood acetate levels were similar in both groups, whereas post-dialysis blood acetate levels were higher in patients treated with conventional bicarbonate dialysate (0.48+/- 0.64 vs. 0.18+/-0.23 mmol/L, p=0.024). Moreover, both periods had similar percentage of patients with pre-dialysis blood acetate levels in the pathologic range, whereas this percentage was higher in post-dialysis samples from patients treated with conventional bicarbonate dialysate respect to acetate-free dialysate (67% vs. 21%, p=0.001). Serum levels of interleukin-6 were statistically higher in the period with conventional bicarbonate dialysate (31.7+/- 24.7 vs. 18.7+/- 10.3 pg/ml, p=0.014), even though other inflammatory markers such as LBP, TNF- and CRP failed to increase in the same period. We didn't found significant differences in the other parameters studied except for the changes in serum concentrations of sodium, chloride and bicarbonate., Conclusions: Acetate-free bicarbonate dialysate does not expose patients to a big amount of acetate and allows that the majority of patients finished hemodialysis with blood acetate levels in the physiologic ranges. Acetate-free dialysate was safe and well tolerated by our hemodialysis patients, although clinical advantages derived from its use should be evaluated in long-term prospective studies.
- Published
- 2007
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.